IL6 and neoplasm: Blockade of IL-6 signaling or TNF-α has already been shown to be effective in reducing tumor growth and metastasis in preclinical studies using PDAC mouse models as well as in the therapy of other tumor entities and inflammatory diseases [52,59,60,61,62,63,64].